Thomas Wallach, MD, discusses phase 3 safety data of tenapanor in pediatric patients with IBS-C, presented at the 2025 NASPGHAN Annual Meeting.
Thomas Wallach, MD
Advertisement
Thomas Wallach, MD, chief, Pediatric Gastroenterology, SUNY Downstate Health Sciences University, New York, New York.
Articles by Thomas Wallach, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Julie Khlevner, MD, AGAF, explains the impact of the FDA approval of linaclotide for pediatric IBS-C
2
Odevixibat demonstrates sustained pruritus and bile acid improvements in FIC1 deficiency
3
Safety, tolerability of tenapanor in pediatric IBS-C patients, with Thomas Wallach, MD
4
Wesley Kufel, PharmD, discusses doxycycline for post-exposure prevention of Lyme disease in young children
5
